about
Antigen-based immunotherapy for autoimmune disease: current statusPreferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation.New insights into the pathophysiology of achalasia and implications for future treatmentAnti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studiesRestoring the balance: immunotherapeutic combinations for autoimmune diseaseBlood gene expression profiling in pediatric systemic lupus erythematosus and systemic juvenile idiopathic arthritis: from bench to bedside.B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis.Role of IL-33 and its receptor in T cell-mediated autoimmune diseasesCardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohortsImmunopathogenesis of ocular Behçet's diseaseStrong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs.Immunotherapeutic strategies in autoimmune uveitisCognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantationActivatory and inhibitory Fcγ receptors augment rituximab-mediated internalization of CD20 independent of signaling via the cytoplasmic domainFrom historical perspectives to modern therapy: a review of current and future biological treatments for Crohn's diseaseNovel fusion proteins for the antigen-specific staining and elimination of B cell receptor-positive cell populations demonstrated by a tetanus toxoid fragment C (TTC) model antigen.Urine metabolome profiling of immune-mediated inflammatory diseases.The relative merits of therapies being developed to tackle inappropriate ('self'-directed) complement activationRheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritisJAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokinesA xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti-IL-6R treatment.Common Adverse Effects of Anti-TNF Agents on Gestation.Biological therapy and dentistry: a review paper.B cells participate in tolerance and autoimmunity through cytokine production.Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.Porcine models of cutaneous wound healing.Immunotherapeutic Biologic Agents in Autoimmune and Autoinflammatory Diseases.Comparative Risk of Harm Associated With the Use of Targeted Immunomodulators: A Systematic Review.Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.Current and future direction in the management of scleroderma.Recent advances in the biologic therapy of lupus: the 10 most important areas to look for common pitfalls in clinical trials.Control of autoimmune inflammation by celastrol, a natural triterpenoid.Challenges to develop novel anti-inflammatory and analgesic drugs.Quantitative glycomics using liquid phase separations coupled to mass spectrometry.Identification of human IgG1 variant with enhanced FcRn binding and without increased binding to rheumatoid factor autoantibody.Biologics in dermatology: adverse effects.Peripheral Ulcerative Keratitis Associated with Autoimmune Disease: Pathogenesis and Treatment.TWEAK/Fn14 Axis-Targeted Therapeutics: Moving Basic Science Discoveries to the Clinic.Characterization of highly concentrated antibody solution - A toolbox for the description of protein long-term solution stability
P2860
Q26852915-839A295E-6AF0-4743-A4AA-D9AE0FDE784AQ27346374-C48AD4CD-321F-4E9A-A0A9-93DE2829542BQ28068914-C48CEB7C-B4D9-4EBE-AA0E-DC2021B01373Q28076199-EE52E7E6-0374-4285-BA5A-C4404D8E45DBQ33555986-4C95944E-A2D0-411D-A4DB-F2BD9D8249CBQ33622723-D7CDB9B3-CC70-4A99-A93A-99F0A12296F4Q33793476-63E388CE-187D-4C8B-A70D-54393E405477Q33854499-B22F6F3E-3D3B-4703-AA89-D084E6F3E3DBQ33879759-78D05678-B558-457C-A67D-E63D049B94B2Q33908937-512D7A04-AE3D-4A77-AB69-176790113039Q34086395-A9FE4204-6177-4B21-92F1-5F0C5DE46006Q34274950-FA436A54-1825-4509-A7DF-AAC97894DF83Q34991001-D06154F0-390D-4B5E-A6EB-C8B70B1DBAA3Q35126604-A1903FCF-3931-417C-9653-5CA7715F6E1DQ35559305-E1595925-E2D9-43B9-8C12-72C0FD76E13CQ35925459-30789F43-93EE-48CF-93B0-2087EBB21BA7Q36127459-C150165F-CFD6-4FB2-A24F-D456C3C9B0AFQ36643354-EA6F0C61-5260-4245-9E53-D75C757FB373Q36673061-FEB918DA-1FCA-44C2-95FC-CB99BF3CCB91Q37148745-BAF24000-2DE6-4AE3-8D62-C3E9E6806370Q37277020-DF4614A0-3149-4336-B233-796092905A54Q37504096-F980DB5C-4CA4-42D6-A6C7-B72EF3B9996AQ37550670-F9867E64-258C-4545-A2DD-0771803903B4Q38163603-180A774F-D227-4040-9AD7-A7602C481394Q38189135-FEEDE7CB-8F9F-4056-9F0A-630869F08D02Q38262461-0DBC5130-D6BE-40E6-B02C-6E31F1414C0BQ38492778-26C28E48-B65C-422D-A29F-1BC6511293DAQ38635412-C9D706A9-75A7-4309-9561-D497EBF3CF12Q38668352-557EC48A-1682-4791-9A93-41768417D4F9Q38729973-0BD82FC4-3F57-42CD-A8FF-6E8E63A0E83DQ38823948-80A0ED74-1D3D-4948-A97A-C6CCBCD22F3EQ38840646-094796A9-A2D7-46D2-AFC6-2E48F8A371D4Q38894091-CBBCC10D-C87A-4E44-B3C9-D2A787474E24Q38941483-9A228D03-D373-4FF5-8DD9-7D5EDADCEB6DQ39124498-27740DCB-C61B-49CF-B3EC-ECD671E9F906Q41104888-1C35D057-BD64-4EE1-BF06-6C36B5CAA1E4Q41120913-990C78D0-D0EB-4622-9403-5732CBBB45DCQ41146632-430A6FD6-9F05-4D35-A7B4-22D4F73E62B0Q42004462-B8B0CC35-102A-49A3-B2DD-E1F97171F358Q42111378-733C829D-12FA-4E69-9794-82E363BFDA65
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Biologic therapy for autoimmune diseases: an update.
@ast
Biologic therapy for autoimmune diseases: an update.
@en
Biologic therapy for autoimmune diseases: an update.
@nl
type
label
Biologic therapy for autoimmune diseases: an update.
@ast
Biologic therapy for autoimmune diseases: an update.
@en
Biologic therapy for autoimmune diseases: an update.
@nl
prefLabel
Biologic therapy for autoimmune diseases: an update.
@ast
Biologic therapy for autoimmune diseases: an update.
@en
Biologic therapy for autoimmune diseases: an update.
@nl
P2860
P356
P1433
P1476
Biologic therapy for autoimmune diseases: an update.
@en
P2093
Ziv Rosman
P2860
P2888
P356
10.1186/1741-7015-11-88
P407
P5008
P577
2013-04-04T00:00:00Z
P5875
P6179
1020533655